EGR1 Suppresses HCC Growth and Aerobic Glycolysis by Transcriptionally Downregulating PFKL

Both in vitro and in vivo assays were employed to examine the impact of EGR1 on the growth of HCC. The mouse HCC model and human organoid assay were utilized to assess the potential of EGR1 as a gene therapy for HCC.